Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al
Case Number:
1:22-cv-00336
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 26, 2023
Del. Judge Nixes Moderna Bid To Toss COVID Vax Patent Suit
A Delaware federal judge on Wednesday swiftly rejected a request from pharmaceutical giant Moderna Inc. to toss patent infringement claims by Alnylam Pharmaceuticals Inc. over its COVID-19 vaccine, calling the request "premature."
-
June 01, 2022
Pfizer Attacks Rival's Claims Over Vaccine Patent In Del.
Pfizer Inc. has ripped into patent infringement litigation brought by a Boston pharmaceutical company that claims to have discovered the mRNA delivery system used in COVID-19 vaccines, telling Delaware's top federal judge that its rival's efforts to make a vaccine had been remarkably "unsuccessful."
-
May 23, 2022
Moderna Wants Claims In COVID-19 Vax Patent Suit Tossed
Moderna Inc. urged a Delaware federal court to nix several claims from an infringement suit claiming it used technology Alnylam Pharmaceuticals Inc. developed that ensures the mRNA in COVID-19 vaccines safely enters the body, arguing Monday that the claims belong in the U.S. Court of Federal Claims.
-
March 17, 2022
Rival Says Pfizer And Moderna Vaccines Rely On Its IP
Alnylam Pharmaceuticals hit Moderna and Pfizer with separate patent infringement lawsuits Thursday, claiming they use technology it developed that ensures the mRNA in their COVID-19 vaccines safely enters the body.